Lannett Co Inc (LCI) 44.22 $LCI Valeant (VRX) in Focus

New Post Public Reply Private Reply Replies (0) Message Board

Oct 23, 2015 at 7:52 PM

Lannett Co Inc (LCI) 44.22 $LCI

Valeant (VRX) in Focus on Intensifying Government Probe
Zacks Equity Research - Zacks Investment Research - Fri Oct 16, 1:20PM CDT
Valeant (VRX) has hit a rough patch ever since concerns arose about the irrational increase in drug prices by U.S. pharma/biotech companies.
LCI: 44.22 (+2.33), VRX: 116.16 (+6.29), ANAC: 102.90 (+10.87)

Prothena to Start Phase IIb Study on AL Amyloidosis Drug
Zacks Equity Research - Zacks Investment Research - Fri Oct 16, 1:10PM CDT
Prothena (PRTA) announced that it will commence a phase IIb study on NEOD001 for patients suffering from AL amyloidosis and persistent cardiac dysfunction.
LCI: 44.22 (+2.33), ANAC: 102.90 (+10.87), PRTA: 49.32 (+2.22)

How Valeant is changing the Pharmaceutical Industry?
Zacks Equity Research - Zacks Investment Research - Thu Oct 15, 3:50PM CDT
It is still early to say if Valeant's (VRX) strategic plan will affect the general behavior of companies operating in the pharmaceutical sector.
IPXL: 35.63 (+1.10), LCI: 44.22 (+2.33), ENDP: 56.60 (+5.14), VRX: 116.16 (+6.29)

Lannett passes US FDA approval for Memantine Hydrochloride Oral Solution, 2 mg/ml to treat dementia associated with Alzheimer's disease
M2 - Thu Oct 15, 3:06AM CDT
Pharmaceutical products business Lannett Company (NYSE:LCI) revealed on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/ml.
LCI: 44.22 (+2.33)

Shire's Cinryze Gets Fast Track Status for Additional Indication
Zacks Equity Research - Zacks Investment Research - Wed Oct 14, 2:45PM CDT
Shire announced that its HAE drug Cinryze has been granted Fast Track designation for antibody mediated rejection (AMR) in renal transplant recipients by the FDA.
LCI: 44.22 (+2.33), SHPG: 213.55 (+9.28), AZN: 31.36 (+0.29)

Lannett Receives FDA Approval For Memantine Hydrochloride Oral Solution, 2 mg/mL
PR Newswire - Wed Oct 14, 5:53AM CDT
Lannett Company, Inc. (NYSE: LCI) today announced that its wholly owned subsidiary, Silarx Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/mL, the therapeutic equivalent to the reference listed drug Namenda® Oral Solution, 2 mg/mL of Forest Pharmaceuticals. According to IMS, for the year ended June 2015 total sales of Memantine Hydrochloride Oral Solution 2 mg/mL at Average Wholesale Price (AWP) were approximately $12 million.
LCI: 44.22 (+2.33)

Zacks Investment Ideas feature highlights: American Woodmark, Footlocker, Lannett, Ryanair Holdings and Carrols
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: American Woodmark, Footlocker, Lannett, Ryanair Holdings and Carrols
LCI: 44.22 (+2.33), RYAAY: 80.74 (+1.89), FL: 63.61 (-5.73), TAST: 12.34 (-0.03), AMWD: 72.48 (+2.08)

Zafgen (ZFGN) in Focus: Stock Plunges 35.6%
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 7:32AM CDT
Zafgen (ZFGN) fell nearly 36% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 44% in the past one month.
ZFGN: 10.44 (-0.23), LCI: 44.22 (+2.33)

5 Best Under the Radar Stocks
Tracey Ryniec - ZACKS - Mon Oct 12, 1:02PM CDT
5 Best Under the Radar Stocks
LCI: 44.22 (+2.33), RYAAY: 80.74 (+1.89), FL: 63.61 (-5.73), AMWD: 72.48 (+2.08), TAST: 12.34 (-0.03)

The Zacks Analyst Blog Highlights: Delta Air Lines, Tyson Foods, United Continental Holdings, Ally Financial and Lannett Company
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: Delta Air Lines, Tyson Foods, United Continental Holdings, Ally Financial and Lannett Company
LCI: 44.22 (+2.33), ALLY: 19.99 (+0.06), DAL: 51.00 (+0.19), TSN: 47.44 (+0.26), UAL: 59.68 (+3.63)

5 Value Stocks That Brokers Love
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 8:40AM CDT
Only a fundamentally strong company has the calibre to achieve its growth potential despite an unsupportive economic background. One such foolproof approach is investing in undervalued stocks that more than 80% brokers recommend.
LCI: 44.22 (+2.33), ALLY: 19.99 (+0.06), DAL: 51.00 (+0.19), TSN: 47.44 (+0.26), UAL: 59.68 (+3.63)

Why Valeant's (VRX) Shares Plummeted in Monday Trading
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 3:41PM CDT
Valeant (VRX) is one of the hardest hit stocks following Hillary Clinton's tweet on "price gouging." The company saw its shares plummet 16.5% yesterday.
ACRX: 3.34 (+0.08), LCI: 44.22 (+2.33), VRX: 116.16 (+6.29), CORT: 3.90 (+0.30)

Jazz Pharmaceuticals (JAZZ) Crumbles: Stock Falls by 7.7%
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 7:42AM CDT
Jazz Pharmaceuticals saw a big move last session, as the company's shares fell nearly 8% on the last trading day
LCI: 44.22 (+2.33), JAZZ: 131.34 (+6.38)

Pacira Pharmaceuticals (PCRX) Crumbles: Stock Falls by 7.7%
Zacks Equity Research - Zacks Investment Research - Thu Sep 24, 7:34AM CDT
Pacira Pharmaceuticals (PCRX) fell nearly 8% in the last trading session amid huge volumes, continuing its recent trend, as the stock is down nearly 18% since Sep 17.
LCI: 44.22 (+2.33), PCRX: 43.38 (+5.38)

Oil, Metals Prices Hurt Stocks; Car Makers, Miners, Biotechs Sacked
at Investor's Business Daily - Tue Sep 22, 9:46AM CDT
Sellers owned the early show on Tuesday, with stocks opening to losses that were broad and deep. The Nasdaq quickly slumped 1.5%. The Dow Jones industrial average and the S&P 500 each dropped 1.3%. Volume was tightly mixed, up 8% on the NYSE and 3%...
SPLS: 12.61 (-0.04), VRX: 116.16 (+6.29), F: 15.67 (+0.09), UTX: 100.62 (+0.83), FCAU: 15.37 (+0.13), NTAP: 34.67 (+0.29), TTM: 29.70 (+0.60), KMX: 58.05 (-0.19), LCI: 44.22 (+2.33), AZO: 762.24 (+0.65), GM: 35.95 (+0.53), MCD: 112.59 (+1.72)

McKesson to Buy UDG Healthcare's Pharmaceutical Business
Zacks Equity Research - Zacks Investment Research - Mon Sep 21, 2:55PM CDT
McKesson Corporation (MCK) signed an agreement to purchase UDG Healthcare's pharmaceutical distribution division for 408 million euro in cash.
LCI: 44.22 (+2.33), MCK: 186.96 (+5.52), ADHD: 6.73 (+0.45)

Major Indexes Still Mixed; Red Hat Up Ahead Of Earnings
at Investor's Business Daily - Mon Sep 21, 1:52PM CDT
Stocks have come off their session lows, but were still mixed late Monday. The Nasdaq cut a 0.6% deficit to 0.2%. But the tech-laden index was up as much as 1.1% intraday. The S&P 500 edged up 0.2% while the Dow Jones industrial average outperformed...
AGN: 268.55 (+15.51), LCI: 44.22 (+2.33), VRX: 116.16 (+6.29), CYBR: 46.10 (-1.24), RHT: 77.39 (+0.42), ILMN: 147.43 (+5.35), REGN: 536.70 (+11.59)

3 Reasons Why Lannett Company (LCI) is a Great Value Stock
Zacks Equity Research - Zacks Investment Research - Fri Sep 18, 7:52AM CDT
Lannett Company is a solid value stock that is very well-positioned for gains in the near term
LCI: 44.22 (+2.33)

'Mad Money' Lightning Round: Buy, Buy, Buy Amazing Starbucks
at The Street - Thu Sep 17, 5:00AM CDT
Cramer prefers Wells Fargo over HSBC Holdings and Kroger over Whole Foods Markets.
WFM: 32.28 (-0.25), SBUX: 62.61 (+1.12), LCI: 44.22 (+2.33), KR: 37.82 (-0.47), HSBC: 39.91 (+0.64), WFC: 54.75 (+0.69)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking Down on Insider Trading: Legal vs Illegal

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Baccarat's Luxe Campaign Courts the High-End Traveler

Shining the Spotlight on a Crystal-Clear Vision When Baccarat decides to cast its net over the high-end travel market, they're not doing it with subtlety. Nope, they're going all out, and why wouldn't they? When you've got a brand that's synonymous with luxury, you have to play the part. Enter Adriana Lima, the supermodel who could probably sell sand in the Maldives if...

Volvo's Q3 2026 Results: Strong Growth and Margin

Volvo Group's Robust Q3 Performance It's not every day that you see a company like Volvo Group churning out results that make you take a second sip of that morning coffee. But here we are—looking at Q3 2026 with growth numbers that pack a punch. You can't argue with SEK 119.5 billion in net sales, especially when organic sales growth hit 7%. That's no small feat in...

Oak View Group Partners with Payactiv for Employee Benefits

Bringing Financial Flexibility to Venue Employees Oak View Group (OVG) has taken a bold step toward enhancing the financial lives of its workforce. They’ve teamed up with Payactiv, the trailblazer in Earned Wage Access (EWA), to deliver a more flexible way for their employees to access funds they've already earned. This move stretches across more than 40 locations...

Amber Intl Unveils AGM Outcomes, Strategic Moves

Diving Into Amber International's AGM Decisions Ah, the hum of shareholder meetings—a fancy little dance of approvals and resolutions! That's exactly what went down on October 23, 2026, for Amber International Holding Limited. A fresh roster, some hefty share awards, and strategic decisions wrapped up their recent annual gathering. Shed the lawyer-speak and let's get...

LCMC Health, Helix Collaborate for Genomics Future

What’s the Big Deal with Genomics? It's not every day you hear about a healthcare initiative aimed at making significant strides in genomics, and right in Louisiana’s backyard no less. LCMC Health has teamed up with Helix in a project that plans to involve 100,000 individuals. That’s a big number in research circles, indicating serious intent to redraw some...

Space Cybersecurity: $8.59B Market Opportunity by 2031

Unraveling the Cybersecurity Frontier in Space These days, keeping our tech safe isn't just about stopping your phone from getting hacked or your laptop from being bombarded with spam. We're talking bigger, and I mean cosmos-level bigger. The space cybersecurity scene is ramping up, projected to balloon from $5.52 billion in 2026 to a whopping $8.59 billion by 2031....

AMTD Digital's Half-Year Results Stir Investor Interest

AMTD Digital Warming Up for a Busy Quarter Some things just catch the wind differently in the market, and when a heavyweight like AMTD Digital starts talking numbers, everybody perks up. They're gearing up to drop their half-year financials, ready to roll out at the stroke of midnight on October 23rd, and investor ears across the globe are pricked for what’s coming down...

Pro Padel League Partners with MGM for Vegas Tourney

Padel Serves Up in Vegas: A Sporting Spectacle When you stumble onto something like padel popping up on the Las Vegas Strip, it raises eyebrows quicker than an unexpected blackjack win. This sport's charging full throttle into the big leagues, and now it's got MGM Resorts International backing it up. November 18 to 21 is when the rackets will be swinging at Dolby Live at...

Barco, VUE Partner to Elevate German Cinemas

Alright, cinema tech enthusiasts, gather up. Remember when going to the movies was just about the popcorn and hoping the ticket lines were short? Now we're witnessing cinema transform into an all-out tech arena, and that’s where Barco and VUE come into play. It seems these folks have decided the German film scene deserves a makeover. Yep, we're talking about pimping out...